IR@PKUHSC  > 北京大学第三临床医学院  > 药剂科
学科主题临床医学
Off-label prescriptions for adult neurological patients: a pilot survey in China
Yi, Zhan-Miao1; Zhai, Suo-Di1; Huang, Sen2; Wang, Tian-Sheng3; Liu, Fang1
关键词China Neurological patients Observational Off-label prescribing Retrospective Supporting evidence
刊名INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
2012-02-01
DOI10.1007/s11096-011-9590-2
34期:1页:81-87
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]PLATELET-AGGREGATION ; CHILDREN
英文摘要

Background Data concerning the extent of off-label prescriptions for adult neurological patients are limited, and the method of assessing supporting evidence in previous studies has some limitations. Objective To improve the method of assessing supporting evidence, determine the status of off-label prescriptions for adult neurological patients, and evaluate the varying levels of supporting evidence. Setting Single, 1,264-bed, tertiary care university hospital in Beijing, China. Method This was a pilot retrospective observational study for adult neurological patients during the period of March 22nd-28th, 2010. Off-label prescriptions were defined according to package inserts. The DRUGDEX system was used to evaluate supporting evidence initially; when information was not available, PubMed/CBM was searched and the grading system proposed by Oxford Centre for Evidence-Based Medicine (OCEBM) was used for categorizing supporting evidence alternatively. Main outcome measure Types, main therapeutic classes and main neurological diseases involved, evidence and recommendation strengths of off-label prescriptions. Results A total of 418 off-label prescriptions were identified from 3,187 prescriptions for 966 patients, 193 from 759 inpatient (25.4%) and 225 from 2,428 outpatient care (9.3%). Most off-label prescriptions were related to unapproved indications. These off-label prescriptions mainly included drugs labeled for nervous system diseases, cerebrovascular diseases, anemia and ophthalmic conditions; and the medication orders were mostly for cerebrovascular diseases. A total of 155 (37.1%) were initially searched and evaluated in the DRUGDEX system; the remaining 263 (62.9%) prescriptions were found in PubMed/CBM search and evaluated by the OCEBM grading system. Sixty-six (34.2%) off-label prescriptions from inpatients and 103 (45.8%) from outpatients were categorized as Class III or Grade D recommendations. Conclusions The improved method provided a supplementary way to study off-label uses. Off-label prescriptions for adult neurological patients mainly concerned unapproved indications, nervous system agents and cerebrovascular diseases, and many of them had inferior level of evidence.

语种英语
WOS记录号WOS:000299329300013
引用统计
被引频次:3[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61073
专题北京大学第三临床医学院_药剂科
北京大学药学院_药事管理与临床药学系
作者单位1.Peking Univ, Dept Pharm, Hosp 3, Beijing 100871, Peoples R China
2.Peking Univ, Dept Hlth Policy & Management, Sch Publ Hlth, Beijing 100871, Peoples R China
3.Peking Univ, Dept Pharm Adm & Clin Pharm, Sch Pharmaceut Sci, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Yi, Zhan-Miao,Zhai, Suo-Di,Huang, Sen,et al. Off-label prescriptions for adult neurological patients: a pilot survey in China[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY,2012,34(1):81-87.
APA Yi, Zhan-Miao,Zhai, Suo-Di,Huang, Sen,Wang, Tian-Sheng,&Liu, Fang.(2012).Off-label prescriptions for adult neurological patients: a pilot survey in China.INTERNATIONAL JOURNAL OF CLINICAL PHARMACY,34(1),81-87.
MLA Yi, Zhan-Miao,et al."Off-label prescriptions for adult neurological patients: a pilot survey in China".INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 34.1(2012):81-87.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yi, Zhan-Miao]的文章
[Zhai, Suo-Di]的文章
[Huang, Sen]的文章
百度学术
百度学术中相似的文章
[Yi, Zhan-Miao]的文章
[Zhai, Suo-Di]的文章
[Huang, Sen]的文章
必应学术
必应学术中相似的文章
[Yi, Zhan-Miao]的文章
[Zhai, Suo-Di]的文章
[Huang, Sen]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。